{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T18:39:01Z","timestamp":1777747141871,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.endien.2023.08.005","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:24:00Z","timestamp":1692264240000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S3","title":["The Tandem Control-IQ advanced hybrid system improves glycemic control in children under 18 years of age with type 1 diabetes and night rest in caregivers"],"prefix":"10.1016","volume":"70","author":[{"given":"Andr\u00e9s","family":"Mingorance Delgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2023.08.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8964027","article-title":"Risk factors for microvascular complications of diabetes in a high-risk Middle East population","volume":"2018","author":"Cheema","year":"2018","journal-title":"J Diabetes Res."},{"key":"10.1016\/j.endien.2023.08.005_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2337\/diacare.27.4.955","article-title":"Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden","volume":"27","author":"Svensson","year":"2004","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endien.2023.08.005_bib0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.endien.2023.08.005_bib0020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endien.2023.08.005_bib0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrendo.2017.3","article-title":"Metrics for glycaemic control - from HbA1c to continuous glucose monitoring","volume":"13","author":"Kovatchev","year":"2017","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.endien.2023.08.005_bib0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/dme.14043","article-title":"Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with type 1 diabetes: a real-world study in the UK","volume":"36","author":"Choudhary","year":"2019","journal-title":"Diabet Med."},{"key":"10.1016\/j.endien.2023.08.005_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dmrr.2653","article-title":"Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics","volume":"32","author":"Pozzilli","year":"2016","journal-title":"Diabetes Metab Res Rev."},{"key":"10.1016\/j.endien.2023.08.005_bib0040","first-page":"794","article-title":"Reduced burden of diabetes and improved quality of life: experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes","volume":"20","author":"Musolino","year":"2019","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.endien.2023.08.005_bib0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.endien.2023.08.005_bib0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/17425247.2014.910192","article-title":"Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems","volume":"11","author":"Tauschmann","year":"2014","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.endien.2023.08.005_bib0055","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4158\/EP-2018-0097","article-title":"Integrated insulin pump and continuous glucose monitoring technology in diabetes care today: a perspective of real-life experience with the Minimed\u2122 670G Hybrid Closed-Loop System","volume":"24","author":"Aleppo","year":"2018","journal-title":"Endocr Pract."},{"key":"10.1016\/j.endien.2023.08.005_bib0060","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.2337\/dc18-1249","article-title":"First look at Control-IQ: a new-generation automated insulin delivery system","volume":"41","author":"Brown","year":"2018","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endien.2023.08.005_bib0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/dia.2019.0011","article-title":"Successful at-home use of the Tandem Control-IQ artificial pancreas system in young children during a randomized controlled trial","volume":"21","author":"Forlenza","year":"2019","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.endien.2023.08.005_bib0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/dia.2020.0507","article-title":"Safety and performance of the Tandem t:slim X2 with Control-IQ automated insulin delivery system in toddlers and preschoolers","volume":"23","author":"Ekhlaspour","year":"2021","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.endien.2023.08.005_bib0075","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4158\/EP-2019-0554","article-title":"Real-world improvements in hypoglycemia in an insulin-dependent cohort with diabetes mellitus pre\/post Tandem Basal-Iq technology remote software update","volume":"26","author":"Pinsker","year":"2020","journal-title":"Endocr Pract."},{"key":"10.1016\/j.endien.2023.08.005_bib0080","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endien.2023.08.005_bib0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/dia.2020.0472","article-title":"Clinical management and pump parameter adjustment of the Control-IQ Closed-Loop Control System: results from a 6-month, multicenter, randomized clinical trial","volume":"23","author":"O\u2019Malley","year":"2021","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.endien.2023.08.005_bib0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1932296819897976","article-title":"The development and psychometric validation of the diabetes impact and device satisfaction scale for individuals with type 1 diabetes","volume":"14","author":"Manning","year":"2020","journal-title":"J Diabetes Sci Technol."},{"key":"10.1016\/j.endien.2023.08.005_bib0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/dia.2020.0388","article-title":"Real-world patient-reported outcomes and glycemic results with initiation of Control-IQ technology","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther."},{"issue":"Suppl 27","key":"10.1016\/j.endien.2023.08.005_bib0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pedi.12737","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes","volume":"19","author":"DiMeglio","year":"2018","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.endien.2023.08.005_bib0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/dia.2020.0646","article-title":"Predictors of time-in-range (70-180 mg\/dL) achieved using a closed-loop control system","volume":"23","author":"Schoelwer","year":"2021","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.endien.2023.08.005_bib0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"A randomized trial of closed-loop control in children with type 1 diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endien.2023.08.005_bib0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/dia.2018.0264","article-title":"Safety evaluation of the MiniMed 670G System in children 7-13 years of age with type 1 diabetes","volume":"21","author":"Forlenza","year":"2019","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.endien.2023.08.005_bib0120","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.802419","article-title":"A comparison of two hybrid closed-loop systems in italian children and adults with type 1 diabetes","volume":"12","author":"Bassi","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"Suppl 1","key":"10.1016\/j.endien.2023.08.005_bib0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2337\/db20-97-LB","article-title":"97-LB: safety and glycemic outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in subjects with T1D","volume":"69","author":"Carlson","year":"2020","journal-title":"Diabetes."},{"key":"10.1016\/j.endien.2023.08.005_bib0130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed Advanced Hybrid Closed-Loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endien.2023.08.005_bib0135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2021.0097","article-title":"One year real-world use of the Control-IQ advanced hybrid closed-loop technology","volume":"23","author":"Breton","year":"2021","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.endien.2023.08.005_bib0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/pedi.12971","article-title":"Real world hybrid closed-loop discontinuation: predictors and perceptions of youth discontinuing the 670G system in the first 6 months","volume":"21","author":"Messer","year":"2020","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.endien.2023.08.005_bib0145","doi-asserted-by":"crossref","first-page":"e14381","DOI":"10.1111\/dme.14381","article-title":"Basal-IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes","volume":"38","author":"Messer","year":"2021","journal-title":"Diabet Med."},{"key":"10.1016\/j.endien.2023.08.005_bib0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00592-021-01789-5","article-title":"Improved technology satisfaction and sleep quality with Medtronic MiniMed\u00ae Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial","volume":"59","author":"Wheeler","year":"2022","journal-title":"Acta Diabetol."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018023001245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018023001245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:17:43Z","timestamp":1762867063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018023001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"alternative-id":["S2530018023001245"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2023.08.005","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Tandem Control-IQ advanced hybrid system improves glycemic control in children under 18 years of age with type 1 diabetes and night rest in caregivers","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2023.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2022.06.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}